Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

WIN 2014 Symposium /
Impact of biomarker-integrated approaches of targeted therapy for lung cancer elimination

23rd - 24th Jun 2014

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Submit
Thanks for rating
There has been a problem, please refresh and try again.
Published: 26.06.14
Views: 3049
Rating:

Prof Waun Ki Hong - University of Texas MD Anderson Cancer Center, Houston, USA

Prof Hong talks to ecancertv at the WIN Symposium 2014 about the impact of the biomarker-integrated approaches of targeted therapy for lung cancer elimination (BATTLE) I trial and how this has influenced the design of the BATTLE 2 clinical study.

Previous conferences: highlights



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation